Shots: The approval is based on SUSTAIN 6 CVOT study assessing Ozempic (0.5mg /1mg, inj.) vs PBO + SOC in 3297 patients with T2D with established CVDs The SUSTAIN 6 […]readmore
Tags : Ozempic
Shots: The intense market competition leads Novo to focus direct-to-consumer campaign for Ozempic, a once weekly Injectable Type 2 diabetes First sales through total diabetic care fell 5% y-o-y with […]readmore